Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.
作者信息
Evens Andrew M, Parsons Susan K
机构信息
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
Departments of Pediatrics and Medicine, Tufts University School of Medicine; and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.
出版信息
J Clin Oncol. 2020 Dec 10;38(35):4131-4134. doi: 10.1200/JCO.20.02668. Epub 2020 Oct 8.
Abstract
摘要
相似文献
1
Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.霍奇金淋巴瘤的连续护理：现代疗法对急性后期发病率和死亡率的影响。
J Clin Oncol. 2020 Dec 10;38(35):4131-4134. doi: 10.1200/JCO.20.02668. Epub 2020 Oct 8.
2
3
The Changing Landscape of Lymphoma Associated with HIV Infection.HIV 感染相关淋巴瘤的变化格局。
Curr Oncol Rep. 2020 Aug 15;22(11):111. doi: 10.1007/s11912-020-00973-0.
4
Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?放射治疗在晚期霍奇金淋巴瘤或非霍奇金淋巴瘤中起作用吗？
Curr Treat Options Oncol. 2016 Jan;17(1):4. doi: 10.1007/s11864-015-0377-x.
5
Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma.青少年及青年非霍奇金和霍奇金淋巴瘤的流行病学、结局、靶向药物及免疫治疗。
Br J Haematol. 2019 Jun;185(6):1142-1157. doi: 10.1111/bjh.15789. Epub 2019 Feb 6.
6
Caring beyond cure: quality of life after high-dose chemotherapy for patients with relapsed Hodgkin lymphoma.关怀超越治愈：复发霍奇金淋巴瘤患者接受大剂量化疗后的生活质量
Leuk Lymphoma. 2010 Nov;51(11):1949-50. doi: 10.3109/10428194.2010.512967.
7
Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.用于霍奇金淋巴瘤和非霍奇金淋巴瘤的检查点抑制剂及其他免疫疗法。
Curr Treat Options Oncol. 2016 Jun;17(6):31. doi: 10.1007/s11864-016-0401-9.
8
Bone marrow transplantation for Hodgkin's disease and lymphoma.用于霍奇金病和淋巴瘤的骨髓移植
Annu Rev Med. 1993;44:255-63. doi: 10.1146/annurev.me.44.020193.001351.
9
[Methylhydrazine in the therapy of malignant lymphopathies].[甲基肼在恶性淋巴病治疗中的应用]
Policlinico Prat. 1967 Jan 16;74(3):82-5.
10
[Standard treatment of malignant lymphoma (Hodgkin's and non-Hodgkin's lymphoma)].[恶性淋巴瘤（霍奇金淋巴瘤和非霍奇金淋巴瘤）的标准治疗]
Nihon Naika Gakkai Zasshi. 2001 Jun 10;90(6):997-1002. doi: 10.2169/naika.90.997.
引用本文的文献
1
Newly Diagnosed Classical Hodgkin Lymphoma: Optimizing Outcomes in a New Therapeutic Era.新诊断的经典型霍奇金淋巴瘤：在新治疗时代优化治疗结果
Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70066. doi: 10.1002/hon.70066.
2
Harnessing multi-source data for individualized care in Hodgkin Lymphoma.利用多源数据为霍奇金淋巴瘤患者提供个体化护理。
Blood Rev. 2024 May;65:101170. doi: 10.1016/j.blre.2024.101170. Epub 2024 Jan 14.
3
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.高级别霍奇金淋巴瘤国际预后指数：来自 HoLISTIC 联盟的临床预测模型的开发和验证。
J Clin Oncol. 2023 Apr 10;41(11):2076-2086. doi: 10.1200/JCO.22.02473. Epub 2022 Dec 10.
4
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.在 I/IIa 期霍奇金淋巴瘤中为放疗决策提供信息：使用辐射剂量学预测预期寿命。
Blood Adv. 2022 Feb 8;6(3):909-919. doi: 10.1182/bloodadvances.2021006254.
本文引用的文献
1
Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.2000-2016 年基于人群的经典霍奇金淋巴瘤患者初始化疗后的病因特异性死亡率。
J Clin Oncol. 2020 Dec 10;38(35):4149-4162. doi: 10.1200/JCO.20.00264. Epub 2020 Sep 18.
2
How I treat advanced Hodgkin lymphoma - a global view.我如何治疗晚期霍奇金淋巴瘤——全球视角
Br J Haematol. 2020 Sep;190(6):837-850. doi: 10.1111/bjh.16587. Epub 2020 Jun 19.
3
Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.在一个主要由新诊断的霍奇金淋巴瘤老年患者组成的队列中，年龄增长与博来霉素肺毒性风险的关系。
J Geriatr Oncol. 2020 Jan;11(1):69-74. doi: 10.1016/j.jgo.2019.09.009. Epub 2019 Oct 24.
4
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.SWOG S0816 研究的 5 年随访结果：III/IV 期霍奇金淋巴瘤行 PET 修正治疗的局限性和价值。
Blood. 2019 Oct 10;134(15):1238-1246. doi: 10.1182/blood.2019000719.
5
Therapeutic recommendations for early stage Hodgkin lymphomas.早期霍奇金淋巴瘤的治疗建议。
Br J Haematol. 2019 Jan;184(1):9-16. doi: 10.1111/bjh.15623. Epub 2018 Nov 28.
6
Current treatment paradigms for advanced stage Hodgkin lymphoma.晚期霍奇金淋巴瘤的现行治疗模式。
Br J Haematol. 2019 Jan;184(1):60-71. doi: 10.1111/bjh.15622. Epub 2018 Nov 8.
7
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.德国、法国和英国经典霍奇金淋巴瘤一线治疗的患者和医生偏好。
Br J Haematol. 2019 Jan;184(2):202-214. doi: 10.1111/bjh.15566. Epub 2018 Sep 21.
8
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.现代早期霍奇金淋巴瘤：模拟建模以描绘长期患者结局。
Br J Haematol. 2018 Jul;182(2):212-221. doi: 10.1111/bjh.15255. Epub 2018 Apr 29.
9
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).儿童癌症幸存者的累积负担：来自圣裘德终身队列研究（SJLIFE）的初步报告。
Lancet. 2017 Dec 9;390(10112):2569-2582. doi: 10.1016/S0140-6736(17)31610-0. Epub 2017 Sep 8.
10
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.早期正电子发射断层扫描反应适应性治疗 I 期和 II 期霍奇金淋巴瘤：随机 EORTC/LYSA/FIL H10 试验的最终结果。
J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.
Zotero 插件